DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer

The results of the present study highly suggest that DNA-PKcs could be a predictive marker of recurrence after radiotherapy, independently of the classic prognostic markers, including the Gleason score modified after review.